Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 35


Incident pregnancy and pregnancy outcomes among HIV-infected women in Uganda and Zimbabwe.

Lancaster KE, Kwok C, Rinaldi A, Byamugisha J, Magwali T, Nyamapfeni P, Salata RA, Morrison CS.

Int J Gynaecol Obstet. 2015 Dec;131(3):255-9. doi: 10.1016/j.ijgo.2015.06.035. Epub 2015 Sep 8.


Evidence of Subclinical mtDNA Alterations in HIV-Infected Pregnant Women Receiving Combination Antiretroviral Therapy Compared to HIV-Negative Pregnant Women.

Money DM, Wagner EC, Maan EJ, Chaworth-Musters T, Gadawski I, van Schalkwyk JE, Forbes JC, Burdge DR, Albert AY, Lohn Z, Côté HC; Oak Tree Clinic Research Group.

PLoS One. 2015 Aug 6;10(8):e0135041. doi: 10.1371/journal.pone.0135041. eCollection 2015.


Risk factors for pre-term birth in a Canadian cohort of HIV-positive women: role of ritonavir boosting?

Kakkar F, Boucoiran I, Lamarre V, Ducruet T, Amre D, Soudeyns H, Lapointe N, Boucher M.

J Int AIDS Soc. 2015 Jun 5;18:19933. doi: 10.7448/IAS.18.1.19933. eCollection 2015.


Antiretroviral Therapy Use During Pregnancy and the Risk of Small for Gestational Age Birth in a Medicaid Population.

Phiri K, Williams PL, Dugan KB, Fischer MA, Cooper WO, Seage GR 3rd, Hernandez-Diaz S.

Pediatr Infect Dis J. 2015 Jul;34(7):e169-75. doi: 10.1097/INF.0000000000000712.


Mitochondrial toxicity in human pregnancy: an update on clinical and experimental approaches in the last 10 years.

Morén C, Hernández S, Guitart-Mampel M, Garrabou G.

Int J Environ Res Public Health. 2014 Sep 22;11(9):9897-918. doi: 10.3390/ijerph110909897. Review.


Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy.

Koss CA, Natureeba P, Plenty A, Luwedde F, Mwesigwa J, Ades V, Charlebois ED, Clark TD, Achan J, Ruel T, Nzarubara B, Kamya MR, Havlir DV, Cohan D.

J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):128-35. doi: 10.1097/QAI.0000000000000281.


Ten years of experience in the prevention of mother-to-child human immunodeficiency virus transmission in a university teaching hospital.

Park JW, Yang TW, Kim YK, Choi BM, Kim HJ, Park DW.

Korean J Pediatr. 2014 Mar;57(3):117-24. doi: 10.3345/kjp.2014.57.3.117. Epub 2014 Mar 31.


Predictors of adverse pregnancy outcomes in women infected with HIV in Latin America and the Caribbean: a cohort study.

Kreitchmann R, Li SX, Melo VH, Fernandes Coelho D, Watts DH, Joao E, Coutinho CM, Alarcon JO, Siberry GK.

BJOG. 2014 Nov;121(12):1501-8. doi: 10.1111/1471-0528.12680. Epub 2014 Mar 7.


Hypertension, preeclampsia and eclampsia among HIV-infected pregnant women from Latin America and Caribbean countries.

Machado ES, Krauss MR, Megazzini K, Coutinho CM, Kreitchmann R, Melo VH, Pilotto JH, Ceriotto M, Hofer CB, Siberry GK, Watts DH; NICHD International Site Development Initiative (NISDI) Pediatric Protocol.

J Infect. 2014 Jun;68(6):572-80. doi: 10.1016/j.jinf.2013.12.018. Epub 2014 Jan 23.


Influence of infection during pregnancy on fetal development.

Adams Waldorf KM, McAdams RM.

Reproduction. 2013 Oct 1;146(5):R151-62. doi: 10.1530/REP-13-0232. Print 2013. Review.


Laboratory Abnormalities Among HIV-Exposed, Uninfected Infants: IMPAACT Protocol P1025.

Read JS, Huo Y, Patel K, Mitchell M, Scott GB.

J Pediatric Infect Dis Soc. 2012 Jun;1(2):92-102. Epub 2012 May 3.


Pregnancy outcomes in HIV-infected women receiving long-term isoniazid prophylaxis for tuberculosis and antiretroviral therapy.

Taylor AW, Mosimaneotsile B, Mathebula U, Mathoma A, Moathlodi R, Theebetsile I, Samandari T.

Infect Dis Obstet Gynecol. 2013;2013:195637. doi: 10.1155/2013/195637. Epub 2013 Mar 7.


Combination antiretroviral use and preterm birth.

Watts DH, Williams PL, Kacanek D, Griner R, Rich K, Hazra R, Mofenson LM, Mendez HA; Pediatric HIV/AIDS Cohort Study.

J Infect Dis. 2013 Feb 15;207(4):612-21. doi: 10.1093/infdis/jis728. Epub 2012 Nov 29.


Antiretrovirals in pregnancy: a note of caution.

Watts DH, Mofenson LM.

J Infect Dis. 2012 Dec 1;206(11):1639-41. doi: 10.1093/infdis/jis581. Epub 2012 Oct 12. No abstract available.


Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.

Chen JY, Ribaudo HJ, Souda S, Parekh N, Ogwu A, Lockman S, Powis K, Dryden-Peterson S, Creek T, Jimbo W, Madidimalo T, Makhema J, Essex M, Shapiro RL.

J Infect Dis. 2012 Dec 1;206(11):1695-705. doi: 10.1093/infdis/jis553. Epub 2012 Oct 12.


Small-for-gestational-age births in pregnant women with HIV, due to severity of HIV disease, not antiretroviral therapy.

Aaron E, Bonacquisti A, Mathew L, Alleyne G, Bamford LP, Culhane JF.

Infect Dis Obstet Gynecol. 2012;2012:135030. doi: 10.1155/2012/135030. Epub 2012 Jun 20.


Maternal HIV infection associated with small-for-gestational age infants but not preterm births: evidence from rural South Africa.

Ndirangu J, Newell ML, Bland RM, Thorne C.

Hum Reprod. 2012 Jun;27(6):1846-56. doi: 10.1093/humrep/des090. Epub 2012 Mar 21.


Pregnant women's access to PMTCT and ART services in South Africa and implications for universal antiretroviral treatment.

Hussain A, Moodley D, Naidoo S, Esterhuizen TM.

PLoS One. 2011;6(12):e27907. doi: 10.1371/journal.pone.0027907. Epub 2011 Dec 5.


Improved oral bioavailability of lopinavir in melt-extruded tablet formulation reduces impact of third trimester on lopinavir plasma concentrations.

Else LJ, Douglas M, Dickinson L, Back DJ, Khoo SH, Taylor GP.

Antimicrob Agents Chemother. 2012 Feb;56(2):816-24. doi: 10.1128/AAC.05186-11. Epub 2011 Nov 21.


Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy.

Zorrilla CD, Tamayo-Agrait V.

HIV AIDS (Auckl). 2009;1:41-53. Epub 2009 Dec 8.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk